Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
BMC Public Health
|
July 29, 2021
Opioid use disorder treatment disruptions during the early COVID-19 pandemic and other emergent disasters: a scoping review addressing dual public health emergencies
Rita Henderson, Ashley McInnes, Leslee Mackey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 6, 2021
Sapanisertib Plus Exemestane or Fulvestrant in Women with Hormone Receptor-Positive/HER2-Negative Advanced or Metastatic Breast Cancer
Bora Lim, David A Potter, Mohamad A Salkeni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2018
Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma
Kevin R Kelly, Jonathan W Friedberg, Steven I Park, et al.
Archives of Disease in Childhood
|
April 15, 2021
Intrathecal baclofen pumps in the management of hypertonia in childhood: a UK and Ireland wide survey
Rajib Lodh, Sam Amin, Amr Ammar, et al.
JAMA Oncology
|
October 23, 2018
Alisertib in Combination With Weekly Paclitaxel in Patients With Advanced Breast Cancer or Recurrent Ovarian Cancer: A Randomized Clinical Trial
Gerald Falchook, Robert L Coleman, Andrzej Roszak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2019
Randomized Phase III Study of Alisertib or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma
Owen A O'Connor, Muhit Özcan, Eric D Jacobsen, et al.
Cancer Research Communications
|
November 26, 2025
Phase 1b Study of Dazostinag plus Pembrolizumab after Hypofractionated Radiotherapy in Patients with Select Advanced Solid Tumors
Benjamin T Cooper, Wade T Iams, David B Page, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 27, 2019
Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses
Taofeek K Owonikoko, Huifeng Niu, Kristiaan Nackaerts, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
BMC Public Health
|
July 29, 2021
Opioid use disorder treatment disruptions during the early COVID-19 pandemic and other emergent disasters: a scoping review addressing dual public health emergencies
Rita Henderson, Ashley McInnes, Leslee Mackey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 6, 2021
Sapanisertib Plus Exemestane or Fulvestrant in Women with Hormone Receptor-Positive/HER2-Negative Advanced or Metastatic Breast Cancer
Bora Lim, David A Potter, Mohamad A Salkeni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2018
Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma
Kevin R Kelly, Jonathan W Friedberg, Steven I Park, et al.
Archives of Disease in Childhood
|
April 15, 2021
Intrathecal baclofen pumps in the management of hypertonia in childhood: a UK and Ireland wide survey
Rajib Lodh, Sam Amin, Amr Ammar, et al.
JAMA Oncology
|
October 23, 2018
Alisertib in Combination With Weekly Paclitaxel in Patients With Advanced Breast Cancer or Recurrent Ovarian Cancer: A Randomized Clinical Trial
Gerald Falchook, Robert L Coleman, Andrzej Roszak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2019
Randomized Phase III Study of Alisertib or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma
Owen A O'Connor, Muhit Özcan, Eric D Jacobsen, et al.
Cancer Research Communications
|
November 26, 2025
Phase 1b Study of Dazostinag plus Pembrolizumab after Hypofractionated Radiotherapy in Patients with Select Advanced Solid Tumors
Benjamin T Cooper, Wade T Iams, David B Page, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 27, 2019
Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses
Taofeek K Owonikoko, Huifeng Niu, Kristiaan Nackaerts, et al.
Page
of 2